Patents-Review.com
ClassID:

111028 ⎘

C12N2760/18743 - CPC Classification

Classification description:

ssRNA viruses negative-sense; Details; Paramyxoviridae; Rubulavirus, e.g. mumps virus, parainfluenza 2,4; Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Recent Application in this class:
#1
20260069674
2026-03-12

PIV5-BASED COVID-19 VACCINE

 #2
20250319176
2025-10-16

PIV5-BASED COVID-19 VACCINE

 #3
20240309053
2024-09-19

RECOMBINANT HUMAN/BOVINE PARAINFLUENZA VIRUS 3 (B/HPIV3) EXPRESSING A CHIMERIC RSV/PIV3 F PROTEIN AND USES THEREOF

 #4
20240287544
2024-08-29

MODIFIED PIV5 VACCINE VECTORS: METHODS OF MAKING AND USES

 #5
20230287055
2023-09-14

Recombinant human parainfluenza virus type 1 expressing a chimeric RSV/HPIV1 f protein and uses thereof

 #6
20230105376
2023-04-06

PIV5-BASED CORONAVIRUS VACCINES AND METHODS OF USE THEREOF

 #7
20200377908
2020-12-03

Parainfluenza virus 5 based vaccines

 #8
20200277338
2020-09-03

Recombinant human/bovine parainfluenza virus 1 (HPIV1) expressing a chimeric RSV/HPIV1 F protein and uses thereof

 #9
20190216918
2019-07-18

Recombinant mumps virus vaccine

 #10
20180312544
2018-11-01

Recombinant human/bovine parainfluenza virus 3 (B/HPIV3) expressing a chimeric RSV/BPIV3 F protein and uses thereof

 #11
20180044644
2018-02-15

PIV5-based amplifying virus-like particles

 #12
20170327845
2017-11-16

PIV5 as an oncolytic agent

 #13
20170067080
2017-03-09

Parainfluenza virus 5 based vaccines

 #14
20150329874
2015-11-19

Vaccine prepared utilizing human parainfluenza virus type 2 vector

 #15
20150086588
2015-03-26

Parainfluenza virus 5 based vaccines

 #16
20140370050
2014-12-18

PIV5 as oncolytic agent

 #17
20140010840
2014-01-09

Recombinant mumps virus vaccine

 #18
20130052718
2013-02-28

Attenuated human parainfluenza virus, methods and uses thereof

 #19
20130023030
2013-01-24

Recovery of recombinant human parainfluenza virus type 2 (HYPIV2) from cDNA and use of recombinant HPIV2 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens

 #20
20120219582
2012-08-30

INTRANASAL SPRAY-TYPE TUBERCULOSIS VACCINE USING PARAMYXOVIRUS VECTOR

 #21
20110143422
2011-06-16

Recovery of recombinant human parainfluenza virus type 2 (HYPIV2) from cDNA and use of recombinant HPIV2 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens

 #22
20090092635
2009-04-09

HETEROLOGOUS PRIME-BOOST IMMUNIZATION REGIMEN

 #23
20080286848
2008-11-20

Recovery of recombinant human parainfluenza virus type 2 (HPIV2) from CDNA and use of recombinant HPIV2 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens

 #24
20070258997
2007-11-08

Rescue of mumps virus from CDNA

 #25
20070253972
2007-11-01

Rescue of mumps virus from cDNA